Gilead Shot Provides Total Protection From HIV in Trial of Young African Women

An injection given just twice a year could herald a breakthrough in protecting the population that has the highest infection rates.

Related posts

U.S. to Review Social Media Posts of Student and Scholar Visa Applicants

Regulators Approve Lenacapavir for H.I.V. Prevention

When Humans Learned to Live Everywhere